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Abstract: To investigate the use of computed tomography (CT) to measure the mitral valve annulus size
before implantation of a percutaneous mitral valve annuloplasty device in an animal trial. Seven domestic
pigs underwent CT before and after implantation of a Cardioband™ (a percutaneously implantable mitral
valve annuloplasty device) with a second-generation 128-section dual-source CT machine. Implantation
of the Cardioband™ was performed in a standard fashion according to a protocol. Animals were sacrificed
afterwards and the hearts explanted. The Cardioband™ was found to be adequately implanted in all
animals, with no anchor dehiscence and no damage of the circumflex artery (CX) or the coronary sinus
(CS). The correct length of the band as chosen according to the length of the posterior mitral annulus
measured in CT before implantation was confirmed in gross examination in all animals. The device did
not result in a metal artifact-related degradation of image quality. The closest distance from the closest
anchor to the CX was 2.1 ± 0.7 mm in diastole and 1.6 ± 0.5 mm systole. Mitral annulus distance to the
CS was 6.4 ± 1.3 mm in diastole and 7.7 ± 1.1 mm in systole. CT visualization and measurement of the
mitral valve annulus dimensions is feasible and can become the imaging method of choice for procedure
planning of Cardioband™ implantations or other transcatheter mitral annuloplasty devices.
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Abstract To investigate the use of computed tomography
(CT) to measure the mitral valve annulus size before
implantation of a percutaneous mitral valve annuloplasty
device in an animal trial. Seven domestic pigs underwent
CT before and after implantation of a CardiobandTM (a
percutaneously implantable mitral valve annuloplasty
device) with a second-generation 128-section dual-source
CT machine. Implantation of the CardiobandTM was per-
formed in a standard fashion according to a protocol.
Animals were sacrificed afterwards and the hearts ex-
planted. The CardiobandTM was found to be adequately
implanted in all animals, with no anchor dehiscence and no
damage of the circumflex artery (CX) or the coronary sinus
(CS). The correct length of the band as chosen according to
the length of the posterior mitral annulus measured in CT
before implantation was confirmed in gross examination in
all animals. The device did not result in a metal artifact-
related degradation of image quality. The closest distance
from the closest anchor to the CX was 2.1 ± 0.7 mm in
diastole and 1.6 ± 0.5 mm systole. Mitral annulus distance
to the CS was 6.4 ± 1.3 mm in diastole and 7.7 ± 1.1 mm
in systole. CT visualization and measurement of the mitral
valve annulus dimensions is feasible and can become the
imaging method of choice for procedure planning of Car-
diobandTM implantations or other transcatheter mitral
annuloplasty devices.
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FoV Field of view
ICE Intracardiac echocardiography
IVC Inferior vena cava
MR Mitral valve regurgitation
MVR Mitral valve repair
SAFIRE Sinogram-affirmed iterative reconstruction
TAVI Transcatheter aortic valve implantation
TSchG Swiss Animal Protection Law
TSchV Swiss Animal Protection Act
Introduction
Mitral valve repair (MVR) has become the gold standard
therapy for severe mitral valve regurgitation (MR) with
excellent results [1, 2]. However, due to age, comorbidities,
and poor left ventricular function up to 50 % of symptomatic
patients with severe MR are not referred to surgery [3].
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Several new transcatheter techniques have been intro-
duced for treating MR in high risk surgical candidates. The
currently most popular device is the MitraClipTM that
produces a double orifice by clipping the free edges of the
mitral valve together [4]. Other devices are placed through
percutaneous intervention into the coronary sinus with the
aim to reduce the size of the posterior annulus [5, 6].
Further devices use techniques directly addressing the
annulus either mechanically or using energy sources to
shrink the annular tissue. The MitralignTM device uses a
cinching technique at the mitral valve annulus for reducing
its size. The QuamtumCorTM device reduces the size of the
posterior mitral annulus with radiofrequency ablation [7].
Irrespective of the device used, precise planning of such
minimally invasive procedures is essential. This planning
mainly includes estimations of the required device size for
the individual patient before implantation.
Recently, the CardiobandTM (ValtechCardio, Or Yehu-
da, Israel) direct annuloplasty system was introduced to
closely replicate surgical implant of a posterior annulo-
plasty DacronTM band, with a transfemoral percutaneous
approach [8]. Multidetector computed tomography (CT)
has been used as an imaging modality for pre-procedural
sizing of the device and planning of the CardiobandTM
implantation procedure. Herein we report our initial
experience in the animal model that has been used for the
preclinical evaluation of the device prior to human clinical
trials.
Materials and methods
All animals received human care in compliance with the
Swiss Animal Protection Law (TSchG) and the Swiss
Animal Protection Act (TSchV). The study protocol was
approved by the local Committee for Experimental Animal
Research (Kantonales Veterinäramt des Kantons Zürich,
permission number 161/2012).
Seven domestic pigswith ameanweight of 99.8 ± 6.9 kg
(range 90–112 kg) underwent procedure planning and Car-
diobandTM implantation. CT was performed in all animals
pre- and postoperatively. General anesthesia was induced
with Propofol and maintained with Propofol and Isofluran.
Amiodarone (150–300 mg) was administered preopera-
tively to avoid arrhythmias during the procedure.
After the postoperative CT scan all animals were sacrificed
and the hearts were explanted. The left ventricle’s anterior
wall was split from the middle of the anterior mitral leaflet to
the apex. The correct positioning of the CardiobandTM was
verified and the length was measured at the expanded heart.
CT imaging protocol and data reconstruction
Under general anesthesia, animals were scanned twice—
immediately before and after CardiobandTM implanta-
tion—with a second-generation 128-section dual-source
CT machine (Somatom Definition Flash, Siemens Health-
care, Forchheim, Germany) equipped with an integrated
circuit detector (Stellar, Siemens Healthcare, Forchheim,
Germany) [9]. The data acquisition was synchronized with
the electrocardiogram (ECG) of the animals using retro-
spective ECG-gating, and with the following scan param-
eters: detector collimation 2 9 0.6 9 64, slice acquisition
2 9 0.6 9 128 by means of a z-flying focal spot, gantry
rotation time 0.28 s, tube current–time product 380 mAs/
rotation, and tube voltage 120 kVp.
80 Eighty ml iopromide (Ultravist 370, Bayer
Healthcare, Berlin, Germany) was used as contrast agent
for the CT scans.
All CT data was reconstructed using a slice thickness of
0.6 mm and increment of 0.4 mm using sinogram-affirmed
iterative reconstructions (SAFIRE) at a strength level of 3
[10]. The reconstruction field-of-view (FoV) was set to
200 mm with a pixel matrix of 512 9 512. Images were
reconstructed in 10 % steps of the RR-interval.
Definition of the mitral annulus and CT data analysis
The mitral annulus is a fibrous cord that marks the hinge-
line of the 2 mitral valve leaflets. The anterior border of the
mitral annulus is related to the aortic valve and the right
and left fibrous trigones. In the area of aortic-mitral fibrous
continuity, the distal margin of the left atrial myocardium
over the leaflet defines the hingeline of the anterior mitral
annulus. The area opposite of the fibrous continuity cor-
responds to the posterior mitral annulus [11].
The following measurements in systole (30 % of the
RR-interval) and in diastole (70 % of the RR-interval)
were performed using the multiplanar reformation software
tool installed on the scanner workstation as described in
[12]:
• After reformation in a 2D short-axis a slice was chosen
where the anterolateral and posteromedial commissures
could be identified. The posterior circumferential
distance of the commissures was defined as the
posterior mitral annular circumference and was mea-
sured free-hand (Fig. 1a),
• Shortest distance from the posterior annular circumfer-
ence to the circumflex artery (CX) was measured after
following the CX in its entire length (Fig. 1b),
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• Shortest distance from the posterior annular circumfer-
ence to the coronary sinus was measured after follow-
ing the coronary sinus in its entire length,
• Device length by measuring free-hand the circumfer-
ential length along the device from the first anchor to
the last anchor in a 2D short-axis reformation, and
• Shortest distance of the closest anchor to the CX.
The CardiobandTM device
The CardiobandTM (Valtech Cardio, Or Yehuda, Israel)
consists of a delivery system made for transvenous access
and a Dacron band intended to be anchored sutureless
along the posterior mitral annulus from commissure to
commissure in the beating heart. Iliac artery sizing is not
mandatory prior to the procedure, because access to the
mitral valve is gained through transseptal puncture from
the right atrium which is approached from the femoral
vein. CardiobandTM is fixated along the annulus using a
series of stainless steel anchors delivered through the
implant into the native annular tissue. After implantation,
the band can be contracted or expanded with an adjustment
tool under echocardiographic guidance (Fig. 2). The
adjustment induces a reduction of the distance from com-
missure to commissure and also of the anterior–posterior
diameter, and with that also increases the length of coap-
tation of the anterior and the posterior mitral valve leaflet.
The CardiobandTM is available in different lengths from
73 to 120 mm. The necessary size has to be chosen before
the implantation and depends on the length of the posterior
mitral valve annulus from commissure to commissure. The
planning algorithm for the CT measurements is described
below. The CardiobandTM lengths according to the mea-
surements of the posterior mitral annular circumference
commissure to commissure distance is provided in Table 1.
Fig. 1 CT short-axis reformations parallel to the mitral annulus showing the measurements of the a posterior mitral annular circumference and
the b shortest distance of the posterior mitral annulus to the circumflex artery
Fig. 2 Schematic representation of the CardiobandTM implantation.
The large image shows the CardiobandTM implanted in a cadaver
atrium. The inlay picture shows the CardiobandTM and a schematic of
the anchors used to fix the device at the mitral valve annulus
Table 1 Available Cardio-
bandTM sizes according to the
measurements of the posterior
mitral annular circumference
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Implantation procedure
After preoperative CT, the animals were kept in general
anesthesia and brought to the animal hybrid operating
room. All implantations were performed in a state-of-the-
art hybrid operating theater (Philips monoplane AlluraXper
FD20C) with support of angiography and intracardiac
echocardiography (ICE).
Access was gained through a right-sided, muscle sparing
thoracotomy in the 4th and 5th intercostal space. Access to
the right atrium was gained through a 10 mm DacronTM
prosthesis, sutured to the lower part of the right atrium
close to the inferior vena cava (IVC) with an angulation of
around 45 meant as a neo-IVC. This step was undertaken
because the angulation between the natural IVC and the
mitral annular plane is more acute in pigs compared to
humans. A large port-like construct was placed into the end
of the prosthesis as access for the catheters and devices. A
10Fr sheath was placed in the apex of the heart, a 10Fr
sheath was placed in the femoral artery as access for two
ICE catheters (Acunav, Siemens Healthcare, Forchheim,
Germany) that were used for guiding the implantation.
The first step of the procedure is transseptal puncture to
gain access to the left atrium above the mitral valve. The
CardiobandTM delivery system (transseptal steerable sheath
and implant delivery system) was placed into the left atrium
above the mitral valve over an Amplatz Superstiff (Boston
Scientific, Natick, MA, USA) guide wire. Anchors were loa-
ded through the delivery system individually and advanced
into the anchor channel through the implant. The first anchor
was placed in the anterolateral commissure. Placement of
further anchors was then performed in a counter-clockwise
direction, until reaching the posteromedial commissure.
Every intended anchoring position was confirmed by ICE and
angiography. After complete implantation of the Cardio-
bandTM, it was released from the delivery system. Using a
specialized catheter, the size of the CardiobandTM could be
reduced temporarily to proof functionality of the system, and
therefore restored to its initial size. The implant delivery
system would be then disconnected and the neo-IVC was
ligated close to the atrial anastomosis. The thoracotomy was
closed and the animals were brought to the CT again to
visualize and to measure the length of the CardiobandTM.
After the second CT, the animals were euthanatized and the
heart explanted to visually verify correct or incorrect place-
ment of the anchors and to verify the correct length of the
CardiobandTM chosen before the implantation.
Results
Transseptal puncture and implantation of the first anchor of
the CardiobandTM could be performed in all animals. In all
animals, the implantation of the whole device including
retrieval of the delivery device could be successfully
performed.
After sacrificing the animals, hearts were explanted.
Measurements of the length of the CardiobandTM could be
successfully performed on postoperative CT in all animals.
Gross examination found the CardiobandTM adequately
implanted in all animals, with no anchor dehiscence and no
surrounding structure damage (including no circumflex artery
lesions). In all animals the CardiobandTM was implanted
exactly from commissure to commissure confirming accuracy
of the preoperative performed CT measurements.
Qualitative CT image analysis
The CardiobandTM device did not result in a metal artifact-
related degradation of image quality in any of the animals.
Both the implant and the surrounding structures could be
visualized on postinterventional CT with high quality. The
single anchors are clearly visualized as well as the
adjustment mechanism close to the first anchor (Fig. 3).
Every single anchor can be clearly identified with a
screw placed in the mitral valve annulus. Close to the first
anchor at the anterolateral commissure, the adjustment coil
is located. The unharmed circumflex artery could be
visualized clearly to exclude accidental injury to the vessel
and resulting bleeding or ischemia. The CardiobandTM
itself was not visualized by CT.
In-vivo and ex vivo measurements
The results from in vivo and ex vivo measurements are
summarized in Table 2.
Before implantation, the mitral valve circumference and
the posterior mitral annulus length was 9.9 ± 0.4 cm (range
9.4–10.4 cm) during diastole and 8.94 ± 0.3 cm (range
8.5–9.4 cm) during systole. After implantation, the mean
Cardioband length measured in MDCT was 8.77 ± 0.6 cm
during diastole and 8.59 ± 0.4 cm during systole. Direct
measurements after explantation revealed an average
length of the implant of 9.87 ± 0.7 mm (Fig. 4).
The distance from the posterior mitral annulus to the CX
varied among the animals, with a median distance of
3.3 ± 0.8 mm (range 3–6 mm) in diastole and
3.9 ± 1.2 mm during systole (range 1–3 mm) (see Fig. 1b).
The distance from the posterior mitral annulus to the
coronary sinus varied among the animals, with a median
distance of 6.4 ± 1.3 mm (range 4–8 mm) in diastole and
of 7.7 ± 1.1 mm during systole (range 6–9 mm).
After implantation of the CardiobandTM, the closest dis-
tance from the closest anchor to the CX was 2.1 ± 0.7 mm
(range 1–3 mm) in diastole and 1.6 ± 0.5 mm (range
1–2 mm) in systole (see Fig. 3).
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Discussion
To the best of our knowledge, this study is the first to
describe the results from pre- and postoperative CT eval-
uation of a direct annuloplasty device. We provide mea-
surements of the posterior mitral annulus with CT pre- and
postoperatively and after intervention in explanted hearts in
an animal study during preclinical evaluation of the Car-
diobandTM system, a direct annuloplasty device replicating
a surgical posterior annuloplasty band procedure.
Surgical MVR is the gold standard therapy for MR [1,
2]. Since few years, new concepts and devices are devel-
oped for off-pump interventions to avoid the need of car-
diopulmonary bypass and cardioplegia. Former devices
Fig. 3 CT reformations after
CardiobandTM implantation a in
the short-axis and b in the long
axis of the left ventricle.
c Measurements of the device
length after implantation and
d 3D volume rendered image of
the implant. Zoomed maximum
intensity image e illustrates the
close spatial relationship of the
anchors of the device to the CX
(arrow)
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focused on the CS. The MONARC and the CARILLON
device are placed in the CS via a catheter and are intended
to improve leaflet coaptation in secondary mitral valve
regurgitation [5, 6]. The concept of these devices was
shown to be feasible, but clinical results are not yet con-
vincing. Main issues are the variability of the coronary
sinus anatomy and the potential for compressing the cir-
cumflex artery. More recently, direct annuloplasty has
gained growing interest, as the ideal approach for percu-
taneous mitral valve annuloplasty. The CardiobandTM
device is intended to be anchored directly to the mitral
valve posterior annulus from commissure to commissure.
Promising results are available from an animal trial with
direct atrial approach [8]. An important issue of such
procedures is precise planning and pre-procedural choice
of the correct implant size. Standard modality for mitral
valve imaging pre-, post- and intraoperatively actually is
transesophageal echocardiography (TEE) [2, 13, 14]. One
major concern about TEE is operator dependency and
reproducibility of echocardiographic results [15]. Besides
TEE, CT has been described for assessment of the mitral
valve anatomy for patients with normal renal function that
can be harmed with contrast medium. Delgado and col-
leagues assessed mitral valve anatomy and geometry with
64-slice CT in a cohort of 151 consecutive patients [16].
Besides others, they measured mitral valve area, diameter
from commissure to commissure and anteroposterior
diameter. Patients with and without secondary MR were
compared, and differences in mitral valve geometry were
demonstrated. However, no systematic surgical assessment
of the patients was available to confirm their CT
measurements.
In a study performed by our group, we assessed the
three-dimensional shape of the mitral valve in order to
produce patient-specific annuloplasty rings in an animal
experiment [17]. In this study, CT was used to produce an
exact model of the mitral valve annulus. In a rapid proto-
typing procedure, rings were produced from these models






























Animal 1 112 10.4/9.4 9.4/9.2 10.5 3/3 1/2 4/6
Animal 2 99.5 9.4/8.8 8.4/8.2 – 3/3 2/2 6/7
Animal 3 103 9.8/9.0 8.9/8.7 9 3/3 3/2 7/9
Animal 4 90 9.9/9.0 8.3/8.5 9.7 5/6 3/1 8/9
Animal 5 95 9.8/8.5 8.1/8.5 9.7 3/4 2/2 7/7
Animal 6 97.5 9.7/8.9 8.5/8.2 9.5 3/3 2/1 6/8
Animal 7 101.5 10.3/9.0 8.9/8.8 10.8 4/5 2/1 7/8
Fig. 4 Explanted pig heart after
removal of the left atrium. a The
CardiobandTM is anchored in
the posterior mitral annulus
from commissure to
commissure along the posterior
leaflet. b Outspread mitral
annulus for manual
measurement of the length of
the device
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and implanted in 6 healthy pigs. It could be observed, that
the shape of the rings matched almost perfectly to the
annular circumference. From this data, we concluded that
assessment of the mitral annulus with CT is feasible and
offers an exact visualization of the structures of interest. In
a recent study by Wang and colleagues [18], CT was used
as basis for finite element modeling of the mitral valve.
Only one patient was identified as eligible out of a database
for the study due to sufficient image quality. From these
images a model of the whole mitral valve within systole
and diastole could be constructed. This confirms the role
and the importance of use and improvement of CT imaging
in mitral valve disease. In our study we compared the
annular dimension in systole and diastole, too. We found
the posterior annulus length to be decreased around 10 %
during systole. This corresponds to in vivo findings in
humans [19]. We could not find in the literature such
measurements in animals.
In this study, CT reliably predicted posterior annular
size in all animals undergoing the procedure. Compared to
baseline, annular size was slightly reduced in the follow-up
CT, especially compared to the diastolic measurement, due
to some residual cinching after CardiobandTM implanta-
tion. The CardiobandTM was intentionally disconnected
with minimal amount of cinching in this study to focus on
CT sizing performance. However, we must acknowledge
the study limitation that our animal population was rather
homogenous in size, and our results suggest that a
9.5–10 cm ring could have been used in all animals.
In addition, CT allowed for an evaluation of the shortest
distance from the posterior mitral annulus to the CX and to
the coronary sinus prior to intervention, and allowed for a
depiction of the spatial relationship and distance of the
closest anchor to the CX and coronary sinus after Cardio-
bandTM implantation. The distance from the anchor to the
CX varied between 1 and 3 mm in this study. No injuries or
impingements of the CX were found in gross examination.
Nevertheless, this remains a potential complication of the
procedure. Therefore, we consider it important to obtain
precise imaging of these structures prior to implantation to
be aware of the exact close anatomical proximity which
might increase the risk of these complications. Together
these findings support the use of CT as an adjunct to TEE
for procedure planning and for post-interventional control
in mitral valve procedures for ongoing and future clinical
trials.
Currently, CardiobandTM is under clinical evaluation in
a feasibility and safety human trial. Patient selection and
device sizing is strongly supported by CT derived imaging.
CT is used to size the annulus, in a similar fashion to what
described here, and to guide device size selection. In
addition, CT offers invaluable information relative to
anatomy of the annulus, relationship with the circumflex
artery, and presence and quantification of annular or leaflet
calcification, which would be a contraindication for any
annuloplasty procedure.
Another fact underlining the importance of CT as
planning tool is that in contrast to mitral valve interven-
tions, for transcatheter aortic valve implantation (TAVI)
procedures, computed tomography already has become the
standard imaging modality to plan the procedure [20] due
to its versatility, 3D nature and low interobserver
variability.
Besides transcatheter MVR, MV replacement will be an
important alternative therapie for high risk patients with
MV disease in the future. Several prosthesis are under
preclinical evaluation or have already witnessed their first-
in-human implantation [21]. For planning of these proce-
dures, as for TAVI procedures, CT will be a very important
imaging tool.
In conclusion, preoperative measured length of the dis-
tance between postero-medial and antero-lateral commis-
sure adequately predicted the necessary length of the
CardiobandTM to be implanted as shown by the gross
examination after explantation of the hearts. Postoperative
CT showed the intentionally cinched and released Car-
diobandTM a little shorter then measured after explantation.
This might be explained by the ‘‘floppy’’ character of the
heart after explantation: The CardiobandTM then expands
to its initial length but not in the beating heart.
In conclusion, transvenous implantation of a Cardio-
bandTM at the posterior mitral annulus is feasible in an
acute animal model. CT visualization and measurement of
the mitral valve annulus dimensions can become the
imaging method of choice for procedure planning before
implantation of a CardiobandTM or other transcatheter
devices that are already available or will be available in the
future.
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